A comprehensive, nearly two-decades long study of the DTaP vaccine that’s routinely given to babies and young children finds no safety issues. “No new or unexpected adverse events were detected” with use of the diphtheria-tetanus-acellular pertussis (DTaP) shot over 19 years of follow-up, concluded a team led by Dr. Pedro Moro, of the U.S. Centers for Disease Control and Prevention. The shot protects against three potentially serious infectious diseases of childhood, including whooping cough (pertussis). In recent years, the “anti-vaxxer” movement — a small minority of parents — has raised concerns that routine childhood immunizations might carry long-term health risks for kids. These concerns persist despite numerous studies showing no link between childhood vaccines and conditions such as autoimmune dysfunction or autism. The latest study seems to add to that body of evidence. Moro’s team focused on the DTaP vaccine, which is routinely advised as a five-dose series given at ages 2 months, 4 months, 6 months, 15 to 18 months and then again between the ages of 4 and 6 years. Millions of U.S. children have received the DTaP vaccine, and the CDC team looked through about 50,000 “adverse effect” reports tied to the shot. The investigators noted that… Read full this story
- Taking on tradition, baseball seeks tobacco ban
- Baseball contract limits tobacco use
- Senators urge MLB to ban tobacco
- AP NewsBreak: Dems urge baseball to test for HGH
- Should pro leagues allow PEDs?
- Concussions can be fought from neck up
- "I'm A Grown-Up Now": The Teen Who Accused Kevin Johnson Of Sexual Abuse Speaks Out
- Steroids a hidden problem in NCAA?
- Steroids loom in major-college football
- Focus on player safety aims at youth
DTaP Vaccine Safe for Kids: CDC Study have 263 words, post on www.newsmax.com at June 11, 2018. This is cached page on MMOR. If you want remove this page, please contact us.